Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. (2022)
Attributed to:
MICA VACCINE FAPESP MICA: Pulmonary Delivery of a Targeted Mucosal Nanocarrier Vaccine for Pneumonia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/pharmaceutics14061238
PubMed Identifier: 35745810
Publication URI: http://europepmc.org/abstract/MED/35745810
Type: Journal Article/Review
Volume: 14
Parent Publication: Pharmaceutics
Issue: 6
ISSN: 1999-4923